Clinical Trials for Systemic Lupus Erythematosus (SLE)

SG301-SC Injection Safety Study in Subjects With Systemic Lupus Erythematosus

NCT ID: NCT06144710

The SG301-SC Injection Safety Study is a clinical trial focused on evaluating a new treatment for people with Systemic Lupus Erythematosus (SLE), a condition where the immune system attacks the bod...

An Extension Study to Learn More About the Long-Term Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus

NCT ID: NCT05352919

Blinatumomab in Refractory Active Childhood Systemic Lupus Erythematosus

NCT ID: NCT06789107

This clinical trial is studying a medication called blinatumomab to see if it can help children and adults with systemic lupus erythematosus (SLE) who have not responded well to other treatments. T...

Safety, Efficacy and Cellular Metabolic Dynamics of ct1192 in Patients With Moderate to Severe Refractory SLE

NCT ID: NCT07031713

This clinical trial is testing a new treatment called CT1192 for people with moderate to severe systemic lupus erythematosus (SLE), a condition where the immune system attacks the body’s own tissue...

INTERSTELLAR - International Study Evaluating Lupus Outcomes After Anifrolumab Real World Use

NCT ID: NCT06314282

The INTERSTELLAR study is a research trial designed to learn more about the effects of a medication called Anifrolumab for people with Systemic Lupus Erythematosus (SLE), a chronic autoimmune disea...

Study of YK012 in Moderate to Severe Systemic Lupus Erythematosus

NCT ID: NCT07010835

This clinical trial is looking at a new treatment called YK012 for people with moderate to severe systemic lupus erythematosus (SLE), which is an autoimmune disease that can cause inflammation and ...

A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

NCT ID: NCT06308978

This clinical trial is studying a new treatment called FT819 for adults with moderate to severe active systemic lupus erythematosus (SLE), a condition where the immune system mistakenly attacks hea...

A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases

NCT ID: NCT06978647

This clinical trial is looking at a new treatment called YTS109 cells for adults who have relapsed or refractory autoimmune diseases, which means their conditions have either come back or have not ...

A Study of OL-108 in Relapsed/Refractory Autoimmune Diseases

NCT ID: NCT06980597

This clinical trial, called the "Study of OL-108 in Relapsed/Refractory Autoimmune Diseases," is investigating a new treatment, OL-108, for adults suffering from specific autoimmune diseases, inclu...

CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus

NCT ID: NCT06839976

This clinical trial is exploring a new treatment called CART19, which involves using specially modified immune cells to help children and young adults with Systemic Lupus Erythematosus (SLE) who ha...

An Exploratory Clinical Study of Anti-CD19 CAR NK Cells in the Treatment of Systemic Lupus Erythematosus

NCT ID: NCT06010472

This clinical trial is exploring a new treatment for patients with a condition called systemic lupus erythematosus (SLE), which can cause a range of symptoms and affect multiple organs in the body....

Universal CAR-T (CHT101) Cell Therapy for Relapsed Refractory Systemic Lupus Erythematosus

NCT ID: NCT06946485

This clinical trial is testing a new treatment called CHT101, a type of cell therapy, for patients with systemic lupus erythematosus (SLE) who have not responded to standard treatments or have expe...

An Open-label Study of GB261 in Refractory Seropositive Systemic Lupus Erythematosus

NCT ID: NCT06945068

This clinical trial is testing a new treatment called GB261 for patients with a type of autoimmune disease known as systemic lupus erythematosus (SLE), specifically for those who have not responded...

Descartes-08 for Patients With Systemic Lupus Erythematosus

NCT ID: NCT06038474

The Descartes-08 clinical trial is studying a new treatment called Descartes-08 CAR T-cells for patients with Systemic Lupus Erythematosus (SLE), a condition where the immune system attacks healthy...

Research Accelerated by You Lupus Registry

NCT ID: NCT06927219

The Research Accelerated by You (RAY) Lupus Registry is a study designed to gather important information about lupus, a chronic condition that can affect many parts of the body. The aim is to bette...

A Phase 1 Trial to Evaluate the Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of VIS171 in Participants With Autoimmune Disease(s)

NCT ID: NCT06799520

This clinical trial is looking at a new treatment called VIS171 for people with certain autoimmune diseases, including Systemic Lupus Erythematosus (SLE), Alopecia Areata (AA), and Immune-mediated ...

A Study to Assess CLBR001+SWI019 in Subjects With Autoimmune Diseases

NCT ID: NCT06913608

This clinical trial is investigating a new treatment combining two medications, CLBR001 and SWI019, for patients with certain autoimmune diseases, including systemic lupus erythematosus (SLE), syst...

Equecabtagene Autoleucel Injection (Eque-cel) for Relapsed/Refractory Systemic Lupus Erythematosus (SLE)

NCT ID: NCT06902844

This clinical trial is looking at a new treatment called Equecabtagene Autoleucel Injection (Eque-cel) for people with systemic lupus erythematosus (SLE) who have not responded well to other treatm...

A Study of CAR-T Cells in Subjects With Systemic Lupus Erythematosus

NCT ID: NCT06900764

This clinical trial is exploring a new treatment called CAR-T cell therapy for people with Systemic Lupus Erythematosus (SLE), a condition where the immune system mistakenly attacks healthy tissues...

A Phase 1 Study of DB-2304 in Healthy Adults and SLE Participants

NCT ID: NCT06625671

This clinical trial is studying a new medication called DB-2304 to see how safe it is and how it works in both healthy adults and adults with Systemic Lupus Erythematosus (SLE), a disease that can ...